211 related articles for article (PubMed ID: 33718163)
1. High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer.
Cha YJ; Bae SJ; Kim D; Ahn SG; Jeong J; Koo JS; Yoo TK; Park WC; Lee A; Yoon CI
Front Oncol; 2021; 11():609743. PubMed ID: 33718163
[TBL] [Abstract][Full Text] [Related]
2. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
[TBL] [Abstract][Full Text] [Related]
3. YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation.
Park I; Lee Y; Kim JH; Bae SJ; Ahn SG; Jeong J; Cha YJ
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894401
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer.
Lee Y; Bae SJ; Eun NL; Ahn SG; Jeong J; Cha YJ
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291755
[TBL] [Abstract][Full Text] [Related]
5. Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance.
Feng Y; Ci H; Wu Q
Medicine (Baltimore); 2021 Aug; 100(34):e27032. PubMed ID: 34449481
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy.
Guimei M; Alrouh S; Saber-Ayad M; Hafezi SA; Vinod A; Rawat S; Wardeh Y; Bakkour TM; El-Serafi AT
Breast Cancer (Dove Med Press); 2020; 12():189-199. PubMed ID: 33173331
[TBL] [Abstract][Full Text] [Related]
7. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
Li Y; Hua K; Jin J; Fang L
Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C Inhibits Triple-Negative Breast Cancer Metastasis by Affecting the Expression of YAP1 and Synaptopodin 2.
Gan L; Camarena V; Mustafi S; Wang G
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817810
[TBL] [Abstract][Full Text] [Related]
9. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.
Zhang L; Song X; Li X; Wu C; Jiang J
Biomed Res Int; 2018; 2018():4039173. PubMed ID: 30539010
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer.
Song M; Cheong JH; Kim H; Noh SH; Kim H
Anticancer Res; 2012 Sep; 32(9):3827-34. PubMed ID: 22993325
[TBL] [Abstract][Full Text] [Related]
12. YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.
Andrade D; Mehta M; Griffith J; Panneerselvam J; Srivastava A; Kim TD; Janknecht R; Herman T; Ramesh R; Munshi A
Oncotarget; 2017 Nov; 8(58):98495-98508. PubMed ID: 29228705
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
14. High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer.
Dong T; Yuan Y; Xiang X; Sang S; Shen H; Wang L; Yang C; Li F; Li H; Zheng S
PeerJ; 2020; 8():e10397. PubMed ID: 33240680
[TBL] [Abstract][Full Text] [Related]
15. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
16. Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
García P; Rosa L; Vargas S; Weber H; Espinoza JA; Suárez F; Romero-Calvo I; Elgueta N; Rivera V; Nervi B; Obreque J; Leal P; Viñuela E; Aguayo G; Muñiz S; Sagredo A; Roa JC; Bizama C
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218280
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Yes-Associated Protein-1 (YAP1) Target Gene Signature to Predict Progressive Breast Cancer.
Venkatasubramanian G; Kelkar DA; Mandal S; Jolly MK; Kulkarni M
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407556
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
Lehn S; Tobin NP; Sims AH; Stål O; Jirström K; Axelson H; Landberg G
BMC Cancer; 2014 Feb; 14():119. PubMed ID: 24559095
[TBL] [Abstract][Full Text] [Related]
20. Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.
Meerang M; Bérard K; Friess M; Bitanihirwe BK; Soltermann A; Vrugt B; Felley-Bosco E; Bueno R; Richards WG; Seifert B; Stahel R; Weder W; Opitz I
Mol Oncol; 2016 Oct; 10(8):1255-65. PubMed ID: 27378628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
